Australia's Optiscan Imaging gains on signing new cross-border research deal
22/07/2026 06:30
BUZZ-Australia's Optiscan Imaging gains on signing new cross-border research deal ** Shares of Australia's Optiscan Imaging OIL.AX rise as much as 8.9% to A$0.153
** Stock erases most losses from Tuesday's session
** Company signs a research agreement with US-based Mayo Clinic to test its breast cancer imaging platforms
** Study is designed to potentially generate clinical evidence for planned FDA 510(k) submission, company says
** Stock up 50% YTD, including current session's moves
(Reporting by Shravya Marakini in Bengaluru)
Recent news on Optiscan Imaging
See all newsAustralia's Optiscan rises after FDA filing for surgery imaging device
Brief: Optiscan Imaging Lodges US FDA 510(K) Submission For Inform Digital Pathology Device
Australia's Optiscan rises after imaging more than 80 cases in ACL study
Australia's Optiscan Imaging gains on signing new cross-border research deal
Brief: Optiscan Imaging Lodges US FDA Dossier For Inspecta For Veterinary Market